tyme technologies stock price target

View Tyme Technologies Inc. The average price target represents a.

18qyx0zco2azmm

The analyst firm set a price target for 1000 expecting TYME to rise to within.

. The latest price target for. Based on analysts offering 12 month price targets for TYME in the last 3 months. The average price target is 000 with a high forecast of 000 and a low forecast of 1000000000.

This price target is based on 0 analysts offering 12 month price targets for Tyme Technologies in the last 3 months. The Tyme Technologies Inc stock price fell by -032 on the last day Friday 18th Feb 2022 from 034 to 034. Tyme Technologies stock was trading at 105 on March 11th 2020 when Coronavirus reached pandemic status according to the World Health Organization.

Tyme Technologies Inc. How has Tyme Technologies stock price been impacted by Coronavirus. Its lead candidate is the SM-88 a CMBT that is in a Phase IIIII clinical trial to treat across 15 types of cancer including pancreatic lung breast prostate sarcoma and lymphoma.

TYME real-time stock quote data in-depth charts and a fully built financial calendar to help you invest smart. 1 Wall Street analyst that have issued a 1 year TYME price target the average TYME price target is 950 with the highest TYME stock price forecast at 950 and the lowest TYME stock price forecast at 950. Ad Low riskhigh reward technology stock picks that beat the market.

Ad Many people will never know about these monumental investing opportunities. USD 031 003 882. The current price of Tyme Technologies is the price at which Tyme Technologies is currently trading.

Is a biotechnology company. MarketBeat users like Tyme Technologies stock less than the stock of other Medical companies. Ad Search Ex-Dividend Dates Dividend Calendar All-Star Rankings More.

The average price target is 000 with a high estimate of 000 and a low estimate of 000. The successful prediction of Tyme Technologies future price could yield a significant profit. Tyme Technologies Inc a biotechnology company develops cancer metabolism-based therapies CMBTs in the United States.

During the day the stock fluctuated 533 from a day low at 033 to a day high of 035. The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. The price has fallen in 6 of the last 10 days and is down by.

TYME was reported by Canaccord Genuity on January 4 2018. Get the latest Tyme Technologies Inc. Given the current short-term trend the stock is expected to fall -5829 during the next 3 months and with a 90 probability hold a price between 00687 and 016 at the end of this 3-month period.

31 rows TYME Stock Trend. Webull offers Tyme Technologies Inc TYME historical stock prices in-depth market analysis NASDAQ. The company also offers TYME-19 an.

Tyme Technologies Target Price Projection Tyme Technologies current and average target prices are 031 and 883 respectively. Tyme Technologies stock price prediction is an act of determining the future value of Tyme Technologies shares using few different conventional methods such as EPS estimation analyst consensus or fundamental intrinsic valuation. The Company is focused on developing cancer metabolism-based therapies CMBTs for a range of solid tumors and hematologic cancers.

Tyme Technologies NASDAQTYME Price Target and Consensus Rating. TYME detailed stock quotes stock data. Find the latest Tyme Technologies Inc.

On the other hand Tyme Technologies target price is what analysts think the stock is worth or could sell for in the future. Ad 1000 Strong Buy Stocks that Double the SP. TYME updated stock price target summary.

45 rows Tyme Technologies Incs average analyst price target is higher than 1754 of all US. TYME investment stock information. Find the latest Tyme Technologies Inc TYME stock price forecast 12-month price target predictions and analyst recommendations.

The average TYME stock price target is 950 with a high estimate of 950 and a low estimate of 950. Unlock your access to Motley Fool Stock Advisor and get our top stock picks for 2022. 6558 of MarketBeat users gave Tyme Technologies an outperform vote while medical companies recieve an average of 6744 outperform votes by MarketBeat users.

Stock Price Forecast The 1 analysts offering 12-month price forecasts for Tyme Technologies Inc have a median target of 800 with a high estimate of 800 and a low estimate of 800. TYME stock quote history news and other vital information to help you with your stock trading and investing. The Companys lead clinical CMBT compound SM-88 is an oral investigational modified tyrosine derivative that is hypothesized to interrupt the metabolic.

Analyst ratings historical stock prices earnings estimates actuals.

2pymuzlodmdjjm